The FDA has rejected vatiquinone, requesting that PTC run an additional study to prove the drug's efficacy prior to ...

This webinar offers essential tools and insights to help organisations confidently navigate the BioSecure Act, ensuring they ...

Amid a push to phase out animal testing, Charles River’s Steve Bulera notes that the implementation of alternative methods ...

Aquestive Therapeutics has made a strategic funding agreement worth $75m with RTW Investments to support the potential launch ...

PharmaTher's ketamine product is the first to be approved in an analgesic setting by the FDA, offering competition to opiates ...

Gilead will integrate Interius, the first biotech to push an in vivo CAR-T therapy into the clinic, into its cell therapy ...

Bristol Myers Squibb and SystImmune have announced breakthrough therapy designation from the US Food and Drug Administration ...

Bavarian Nordic bolstered its cash reserves with a $160m sale of a priority review voucher in June 2025. The company has now ...

The FDA has granted approval for Ionis Pharmaceuticals’ Dawnzera (donidalorsen), for use in preventing hereditary angioedema ...

Tariff rates on generic pharmaceutical products imported from the EU to the US will now be “effectively zero or close to zero ...

Before Novo arrived as its owner, issues at the Bloomington facility caused a two-month delay for Eylea HD’s FDA approval ...